ARTICLE | Emerging Company Profile
Intergalactic: A new take on non-viral gene therapy
October 7, 2021 11:14 PM UTC
Apple Tree Partners backs Intergalactic’s non-viral gene therapy platform with $75M
Backed by Apple Tree Partners, Intergalactic launched with a non-viral gene therapy platform designed to avoid the modality’s mounting safety issues while expanding the addressable indications.
Intergalactic Therapeutics Inc. formed last year by bringing together gene therapy technologies that were being incubated as side projects in different Apple Tree Partners portfolio companies. ATP invested $75 million in a tranched series A round...